Blood Pressure Monitoring in Clinical Trials in Obese Subjects

This article summarizes the association between obesity, cardiovascular risk and hypertension and outlines the emerging FDA guidance on the need for blood pressure monitoring in the development of new drugs.

ERT_BPM in Obese Patients_JCS_June 2020
Share